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Background: Forensic psychiatric patients are known to have reduced life expectancy. 
The aim of this study was to explore to what extent substance abuse disorders account 
for this increased mortality.
Methods: Data up to December 31, 2016 for mortality (causes of death register) and 
substance abuse (forensic psychiatric examinations) were collected for all of the 950 
patients committed to involuntary forensic psychiatric hospital care in Finland during 
1980–2009 and discharged no later than December 31, 2016. Patients were then 
classified as suffering or not suffering from substance abuse disorders and their causes 
of death were examined. The standardized mortality ratio was then calculated for these 
groups on the basis of sex-, age-, and calendar-period-specific mortality rates for the 
general Finnish population.
Results: During the follow-up time (mean 13.4 years), 354 (320 men, 34 women) patients 
died, resulting in a standardized mortality ratio of 3.5. The standardized mortality ratio for 
the patients with a history of substance abuse disorders was 4.1 compared to 2.8 for 
those with no such history. Among men, but not women, the age-adjusted proportion of 
death was significantly higher for those with a history of substance abuse disorders. In 
addition, in patients with a history of substance abuse disorders, the male age-adjusted 
competing risk of mortality was higher for unnatural causes, but not natural causes. 
Furthermore, a prominent proportion (16%) of all deaths and a majority of the accidental 
deaths (64%) occurred under the influence of some substance.
Conclusions: Substance abuse is a major factor causing excessive mortality among 
forensic psychiatric patients. The management of substance abuse problems should 
be one cornerstone of the treatment of patients with both severe mental disorders and 
substance abuse disorders during their time in hospital and this should be extended to 
outpatient care.
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INTRODUCTION
All major psychiatric disorders are associated with an increased 
risk of premature mortality (1). The mortality of patients 
discharged from a psychiatric hospital has been found to be 
four-fold higher than the general population in a Finnish sample 
(2). The mortality associated with substance abuse disorders has 
been found to be even higher than that associated with serious 
psychiatric disorders, like schizophrenia, schizoaffective disorder, 
or bipolar disorder (3, 4). This risk for premature mortality 
seems, at least to some extent, to be additive, as patients with 
both comorbid substance abuse and serious mental disorders are 
at an even higher risk (5, 6, 7).
It is not surprising that the mortality of forensic psychiatric 
patients, who often suffer from both serious psychiatric 
disorders as well as substance use disorders (SUDs), is higher 
than that of the general population. In a Swedish sample, the 
mortality of forensic psychiatric patients was found to be 
higher, if the primary diagnosis was that they were suffering 
from a substance abuse disorder (8). This was also the case for 
forensic patients with a secondary diagnosis of a substance 
abuse disorder, unless they were suffering primarily from 
bipolar disorder. However, only 34% of the Swedish sample 
consisted of patients diagnosed with schizophrenia or some 
other psychotic disorder. This sample included patients from 
many decades, and it need be noted that the average treatment 
time of the sample was stated to have been only 5 months, 
which might not reflect current practice. In Finland, in order 
to treat individuals as forensic psychiatric patients, they are 
required to have a diagnosis of a psychotic disorder and the 
average treatment times are on average many years (9). In 
a Finnish study, the mortality among forensic psychiatric 
patients was found to be up to three-fold higher than the 
general population, but somewhat comparable to that of other 
schizophrenia spectrum patients (4, 9). When the causes of 
death were further examined, most of the deaths in the forensic 
psychiatric patients were due to somatic illnesses, although the 
largest difference, i.e., as much as seven-fold elevated risk, was 
attributable to suicide (10).
The problem in extrapolating these data for forensic patients 
from country to country is that the criteria for placing an 
individual into forensic psychiatric care vary between countries, 
as do treatment practices, even though in general, the psychiatric 
treatment protocols might be similar. Thus, results from different 
countries might not be generalizable, unless these criteria and 
their treatment protocols are similar. There is a rather sparse 
literature on the effect of substance abuse disorders on mortality 
in forensic psychiatric patients with psychotic disorders. It is 
evident that a more detailed knowledge of the factors behind 
the increased mortality observed in forensic psychiatric patients 
is needed to guide treatment decisions towards reducing these 
substantial risks.
The aim of this study was to explore the extent to which 
substance abuse disorders contribute to the increased 
mortality observed in forensic psychiatric patients, even when 
treatments times, and thus periods of abstinence, are long. This 
information would be of major clinical interest, since there is a 
dogma surrounding many addictive disorders that the time of 
abstinence itself is a protective factor against relapse and further 
that relapse is a risk factor for increased mortality. If a long 
period of abstinence per se is not sufficient to prevent relapses 
for substance abuse disorders, then it is clear that there is a 
need to devise alternative treatment modalities for patients with 
substance abuse problems in forensic psychiatric hospitals.
MATERIALS AND METHODS
In Finland, the law court decides whether it is necessary to 
perform a forensic psychiatric examination which assesses 
the criminal responsibility of a defendant. Usually defendants 
committing homicides, or individuals who, due to their 
medical history or behaviour in detention, are thought to be 
affected by a psychiatric disorder, are subjected to a forensic 
psychiatric examination. After the forensic psychiatric 
examination, if the defendant is assessed as suffering from a 
serious mental disorder (psychosis or other disorders that affect 
reality testing, but not intellectual disability, autism or SUD by 
themselves), he/she can be exempted from legal punishment 
and be committed to involuntary forensic psychiatric hospital 
care. In the final stage of hospital treatment, the patient can 
be released on supervised leave, although he/she will still be 
under involuntary care. A supervised leave may be granted for 
up to 6 months at a time; furthermore, there can be multiple 
supervised leaves before ultimate hospital discharge. Most 
of the forensic psychiatric patients undergo this form of 
supervised leave prior to their final hospital discharge. After 
the patient’s ultimate discharge from hospital, psychiatric 
outpatient care is not mandatory; in legal terms, ex-forensic 
psychiatric patients are regarded in the same manner as other 
psychiatric outpatients. Finnish legislation does not allow for 
compulsory or involuntary outpatient care for any psychiatric 
patient. The Finnish National Institute for Health and Welfare 
(THL) is responsible for both the initiation and termination of 
involuntary psychiatric forensic hospital care.
Data Acquisition
The material for this study was collected from the Finnish 
National Institute for Health and Welfare’s archive, which 
houses data on all Finnish forensic psychiatric examinations 
and the information of patients who have been committed to 
or released from involuntary forensic psychiatric hospital care. 
The data from patients which constituted this study group were 
then linked to the national cause of death register of Statistics 
Finland, which contains information on all deaths in Finland, 
including data on causes of and events related to death, which 
made it possible to estimate mortality. Standard mortality data 
for the general population, to be used as control data, were also 
retrieved from this register.
Analyses
Our study population consisted of the 950 patients who had 
been committed to involuntary forensic psychiatric hospital 
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care in Finland during the 30-year period from 1980 to 2009 
and were discharged no later than 31.12.2016 (total number 
of patients committed during this time was 1,253). Follow-up 
started on hospital discharge and ended either on 31.12.2016 
or when the patient died, whichever came sooner. The data for 
initial diagnoses (for psychosis and SUDs) were recorded from 
the forensic psychiatric examinations, which were then further 
screened for signs of SUDs not recorded in the diagnoses section, 
since the primary function of the examinations is to provide 
information on the individual’s mental state (e.g., psychotic 
symptomology) and substance abuse disorders are sometimes 
omitted from the diagnoses section as they may be thought to 
either be secondary to the evaluation or to have arisen from the 
psychotic disorder. These data were pooled together to classify 
a patient as suffering or not suffering from an SUD according 
to ICD-10 criteria. Sometimes, it proved difficult to ascertain 
enough information to determine whether the criteria for 
addiction had been fulfilled, although harmful use was clearly 
evident. Patients with current unequivocal evidence of harmful 
use or addiction were classified as having an SUD, regardless 
of which substance was being abused (ICD-10: F1x.1 - F1x.2). 
Those patients for whom there was only evidence of intoxication 
or withdrawal symptoms without a longer standing substance 
abuse disorder, patients with only prior evidence of SUDs 
without current use, or patients without any evidence of an SUD 
were classified as not having an SUD.
Data on causes of death and events related to death from the 
patients were then retrieved up to 31.12.2016 from the cause of 
death register, and the causes of death were then categorized as 
being due to somatic diseases, suicides, accidents, homicides, 
or unclear. If signs of substance use at time of death or prior to 
death were evident from the death certificates, these were also 
recorded.
The Standardized Mortality Ratio (SMR) was then calculated 
for all patients, grouping the patients as either suffering or not 
suffering from SUD as described above. The SMR was calculated 
as the ratio of observed and expected number of deaths by using 
subject-years methods with 95% confidence intervals, assuming 
a Poisson distribution. The expected number of deaths was 
calculated on the basis of sex-, age-, and calendar-period-specific 
mortality rates in the general Finnish population. We used Cox 
proportional hazards model to calculate the age adjusted hazard 
ratios HR for death and adjusted survival (failure) function. A 
competing-risks regression model (Fine and Gray model) with 
a robust estimate of variance served to estimate the adjusted 
subhazard ratios (sHR) and cumulative incidence in the presence 
of competing risks. Stata 15.0 (StataCorp LP, College Station, TX, 
USA) statistical package was used for the analysis.
Ethical Considerations and Approval
This study is a part of the transnational After Care project. Ethics 
committee approvals for the study were sought and obtained 
from the Research Ethics Committees of Kuopio, Oulu and Turku 
Universities, Kuopio, Helsinki and Turku University Hospitals, 
Healthcare Centre of the City of Helsinki, Hospital District of 
Southern Savo, and the Hospital District of Pirkanmaa. This 
study was also approved by and the study material gathered 
from the Finnish National Institute for Health and Welfare and 
Statistics Finland. This study was registry based, and no contact 
was made with the study subjects.
RESULTS
There was a total of 950 forensic patients detected and 
included in the analyses. All of the patients were diagnosed as 
suffering from a psychotic disorder; the majority of them had 
a schizophrenia spectrum disorder, more specifically 59% had 
schizophrenia (ICD-10: F20.x), 13% had delusional disorder 
(F22.x), 9% had schizoaffective disorder (F25.x), and the rest 
other psychiatric disorders affecting reality testing, such as 
severe bipolar disorder, psychotic depression, organic brain 
injuries, or severe borderline personality disorder. The vast 
majority (823 = 86.6%) of the 950 forensic psychiatric patients 
were men and 127 (13.4%) were women. The mean duration 
of forensic psychiatric treatment had been 6.7 years [standard 
deviation (SD) 5.5], and the mean age of the patient was 43 years 
(SD 13) at the time of his/her discharge. The mean follow-up 
time was 13.4 years (SD 9.3 years). In Finland, a substance abuse 
disorder in itself is not sufficient grounds for treatment as a 
forensic psychiatric patient, but the majority (567 = 59.7%) of 
the patients (514 men, 53 women) were noted as suffering from 
a comorbid SUD according to ICD-10 criteria (either addiction 
or harmful use) in conjunction with their psychotic disorder. Of 
these 567 patients with an SUD, 395 were diagnosed prior to or 
during the forensic psychiatric examination; the other 172 were 
classified as having an SUD according to the examination notes 
of the forensic psychiatrist, even though no official diagnoses 
had been set for them.
During the follow-up, a total of 354 patients died. The mean 
follow-up time for these patients was 10.3 years (SD 8.1), 
resulting in a SMR of 3.5 for the whole patient population. 
The vast majority of deaths (264 = 74.6%) were attributable to 
somatic diseases; 80 (22.6%) of the deaths were due to unnatural 
causes (accidents, suicides, homicides); and in 10 (2.8%) cases, 
the cause of death had remained undefined even after forensic 
autopsy and had therefore been classified as unclear in their 
death certificate.
Most, 320, of the 354 deceased patients were men and 34 
were women. Among these deceased patients, 218 were noted 
as having a substance abuse disorder during their forensic 
psychiatric examination. The SMR for the patients with an 
SUD was 4.1, whereas the SMR for the patients without an SUD 
was 2.8.
Among men, the age-adjusted proportion of death was 
significantly higher among those with an SUD when compared 
to those without this disorder [hazard ratio (HR) = 1.34, 95% 
confidence interval (95% CI) 1.07 to 1.69, p = 0.012], but this 
kind of difference was not observed among women (HR = 1.00, 
95% CI 0.50 to 2.01, p = 0.99). The age adjusted proportions of 
death are shown in Figure 1.
The age-adjusted competing risk of mortality among men with 
a known SUD was not higher for the risk of death due to diseases 
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(sHR 0.95, 95% CI 0.73 to 1.24, p = 0.70), but was significantly 
higher for the risk of dying from unnatural causes (sHR 2.63, 
95% CI 1.55 to 4.47, p = 0.015). The competing mortality risks 
for men are shown in Figure 2.
Many of the examined death certificates mentioned that 
the current status of substance use preceding death was not 
known, though in many of the cases even when a background 
of substance use was recognized, the relationship between 
substance use and death remained somewhat obscure. 
However, in 56 of the 354 deaths, there was clear evidence 
of current substance use listed in the death certificates, such 
as evidence of intoxication or withdrawal symptoms at time 
of death or the fact that the subject had been found deceased 
with items for substance use, such as needles and syringes or 
alcohol. Of these 56 deceased, 47 had a history of SUD, only 9 
did not (Chi2 statistic 14.04, p > 0.001 for history of an SUD 
vs. evidence of substance use at time of death, Table 1). Deaths 
related to current substance use with regard to history of an 
SUD are presented in Table 1. The numbers of deaths with/
without current evidence of substance use, subdivided into 
causes of death, and the percentage of patients with or without 
clear evidence of current substance use at time of death are 
presented in Table 2.
If one assesses the natural deaths, then the cause of death 
was stated to have been directly caused by substance abuse in 
10 patients; in more specific terms, three had alcohol related 
liver cirrhosis, three had alcohol related heart disease, one had 
combined alcohol related liver cirrhosis and heart disease, one 
had alcohol dementia, and for two, the main cause of death had 
been listed as SUD.
The majority (28/44 = 64%) of the unnatural deaths due to 
accidents were substance related. Fifteen of these deaths were 
attributable to substance overdoses or poisonings, 10 of which 
were alcohol intoxications. Of the remaining 13 substance related 
accidental deaths, four individuals had choked on food, two had 
died of subdural hemorrhage, one had frozen to death, one had 
drowned, one had died due to carbon monoxide poisoning, and 
one had suffocated after passing out in an awkward position, all 
while intoxicated. Three deaths happened during the withdrawal 
stage: one patient had frozen to death, one died of a subdural 
hemorrhage, and one due to clozapine poisoning after an 
extended period of drinking.
In 10 cases, the classification of death was unclear; for example, 
in some cases, it could not be determined whether a blunt force 
trauma was due to an accident or suicide, but in 5 of these cases, 
there was evidence of substance use.
DISCUSSION
Our results show that even after a long period of abstinence 
due to institutionalized forensic psychiatric care, especially 
men with a history of substance abuse disorders, in comparison 
with their counterparts without such a background, still have 
a significantly elevated risk for premature mortality after their 
release from care, especially due to unnatural causes. The same 
phenomenon was not observed in women, but this might be 
due either to actual gender-related differences or possibly 
due to the small sample size of our female study population. 
Furthermore, many of the deaths observed in the patient groups 
FIGURE 1 | Age-adjusted proportions of death in percentages as a function of follow-up time for men and women with or without a substance use disorder.
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actually occurred while the patient was under the influence of 
substances, indicating obvious relapses of their substance abuse 
disorder.
As compared to previous studies investigating this topic, 
the strengths of this study are the large sample of forensic 
psychiatric patients, the prolonged mean follow-up time of 
13.4 years, and the possibility to access the comprehensive 
and validated Finnish national registers (11). One weakness of 
this study was that we were unable to obtain information on 
the living arrangements, medication use and commitment to 
outpatient care, inpatient care episodes, or criminal convictions 
after discharge from the hospital. There was also no information 
available on what kind of treatment, if any, patients had 
received for their SUDs in addition to the forced abstinence 
during their hospital incarceration. Also, as only patients with 
clear evidence of current SUDs from the forensic psychiatric 
examinations were classified as having an SUD, some patients 
with marked substance use, but not clearly reaching diagnostic 
thresholds as assessed from the examination statements, were 
classified as not having an SUD, which serves to dilute the 
results presented here. It need also be noted that some 30% of 
the patients with clear diagnostic evidence of an SUD were left 
without a diagnosis of such in the initial forensic psychiatric 
mental state examinations, which could indicate a serious defect 
in recognizing substance abuse disorders and even possibly led 
to failure to provide proper treatment for them. It is also worth 
noting that knowledge of possible relapses to substance use was 
FIGURE 2 | Age-adjusted competing risk of mortality in percentages as a function of follow-up time in men with or without a substance use disorder for both natural 
and unnatural causes. The figure for unnatural death displays hazard ratios (lines) and confidence intervals (shadings around lines).
TABLE 1 | Number of deaths related to current substance use with regard to 
history of substance use disorder (Chi2 statistic 14.04, p > 0.001).
Chi2 Deaths related to 
current substance use
Deaths unrelated to 
current substance use
History of SUD 47 171
No history of SUD 9 127
TABLE 2 | Number of deaths with/without current evidence of substance use 
subdivided into causes of death and by gender. The percentage of patients with 
or without clear evidence of current substance use at time of death is given in 
parentheses.
Men Women Total
Suicide
 – substance use related
 – substance use unrelated
3
27
0
3
33
 – 3 (9%)
 – 30 (91%)
Accident
 – substance use related
 – substance use unrelated
27
14
1
2
44
 – 28 (64%)
 – 16 (36%)
Homicide
 – substance use related
 – substance use unrelated
1
2
0
0
3
 – 1 (33%)
 – 2 (67%)
Unclear
 – substance use related
 – substance use unrelated
5
5
0
0
10
 – 5 (50%)
 – 5 (50%)
Disease
 – substance use related
 – substance use unrelated
18
218
1
27
264
 – 19 (7%)
 – 245 (93%)
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only available for those patients in whom it was mentioned in 
their death certificates. Thus, it is possible, perhaps even likely, 
that the overall rates of substance use relapses were higher. Some 
of the patients in the “no prior history of substance abuse” group 
might also have developed SUDs during their follow-up time, 
i.e., the present findings may be an underestimation. The data 
are thus subject to confounding by indication. In addition, as 
the current study is an observational registry based study, the 
data presented are only correlations, and only speculations of 
causality can be made.
In this study, the presence of substance abuse was found 
to contribute to mortality in the background of some somatic 
diseases, but it was especially evident in the large proportion 
of deaths due to accidents. Thus, although substance abuse 
might not be the only problem responsible for poor coping 
in some individuals, it is likely to be a major factor causing 
excessive mortality among forensic psychiatric patients 
due to both natural and unnatural causes. Therefore, the 
management of substance abuse disorders should receive a 
high priority in this patient group, in an attempt to reduce 
the excessive mortality as well as gaining other health benefits 
associated with reduced substance use. When viewed against 
the background of the long psychiatric hospital treatment 
provided for these patients, these results must be viewed both 
as a sign that abstinence in itself is not sufficient to prevent 
relapses and able to reduce the excessive mortality, but also as 
an indication of a failure to provide treatment modalities with 
greater efficacies.
CONCLUSION
According to our study, a history of substance abuse is related to 
the excessive mortality observed in Finnish forensic psychiatric 
patients. Thus, the integrated management of addiction problems 
should be one cornerstone of the treatment of patients with 
both severe mental disorders and substance abuse disorders 
not only during their time in hospital but also extended to their 
outpatient care.
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